Meng Yuan, MS

Jinan, Shandong

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2926 - ILT4, Immunosuppression, and Resistance to Radioimmunotherapy (iRT) in Non-Small Cell Lung Cancer (NSCLC) through Recruiting SHP2 to Induce Mitochondrial Oxidative Stress-Mediated Tumor-Associated Mac

  Monday, September 30, 2024
  5:00 PM – 6:00 PM ET